| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Group Pharmaceuticals Limited |
| PARTICULARS | 31 March 2022 | 31 March 2021 |
| Equity & Liabilities | ||
| Shareholders Funds | ||
| Share Capital | 253.68 | 253.68 |
| Reserves and Surplus | 4,178.35 | 3,695.43 |
| Money Received Against Share Warrants | 0.00 | 0.00 |
| Share Application Money Pending Allotment | 0.00 | 0.00 |
| Non-Current Liabilities | ||
| Long Term Borrowings | 0.00 | 0.00 |
| Deferred Tax Liabilities | 0.00 | 0.00 |
| Other Long Term Liabilities | 0.00 | 0.00 |
| Long Term Provisions | 204.18 | 0.00 |
| Current Liabilities | ||
| Short Term Borrowings | 213.02 | 92.00 |
| Trade Payables | 800.23 | 540.86 |
| Other Current Liabilities | 478.35 | 593.07 |
| Short Term Provisions | 53.41 | 0.00 |
| Total Equity and Liabilities | 6,181.22 | 5,175.04 |
| Assets | ||
| Non-Current Assets | ||
| Fixed Assets | ||
| Tangible Assets | 1,534.89 | 1,635.54 |
| Intangible Assets | 7.31 | 8.18 |
| Capital Work-in-Progress | 11.67 | 0.00 |
| Intangible Assets Under Development | 0.00 | 0.00 |
| Non-Current Investments | 0.00 | 0.00 |
| Deferred Tax Assets | 19.49 | 11.78 |
| Long Term Loans and Advances | 142.68 | 119.62 |
| Other Non-Current Assets | 0.00 | 0.00 |
| Current Assets | ||
| Current Investments | 0.00 | 0.00 |
| Inventories | 1,381.98 | 1,458.59 |
| Trade Receivables | 2,214.35 | 1,399.54 |
| Cash and Cash Equivalents | 554.78 | 239.45 |
| Short Term Loans and Advances | 292.96 | 269.54 |
| Other Current Assets | 21.11 | 32.80 |
| Total Assets | 6,181.22 | 5,175.04 |
| PARTICULARS | 31 March 2022 | 31 March 2021 |
| Revenue from operations | 13,029.35 | 10,465.33 |
| Other income | 77.34 | 96.89 |
| Total revenue | 13,106.69 | 10,562.22 |
| Cost of materials consumed | 4,812.50 | 3,714.94 |
| Purchases of stock in trade | 1,342.32 | 954.48 |
| Changes in inventory | 110.57 | 99.31 |
| Employee benefit expenses | 3,521.77 | 3,063.55 |
| Finance costs | 34.24 | 65.89 |
| Depreciation and amortization | 205.65 | 222.20 |
| Other expenses | 2,410.60 | 1,952.09 |
| Total expenses | 12,445.66 | 10,089.53 |
| Total revenue less total expenses | 661.03 | 472.69 |
| Prior period and exceptional items | 0.00 | 0.00 |
| Profit before extraordinary items | 661.03 | 472.69 |
| Extraordinary items | 0.00 | 0.00 |
| Profit before tax | 661.03 | 472.69 |
| Current tax expense | 185.81 | 170.52 |
| Deferred tax expense | -7.70 | -3.71 |
| Profit from continuing operations | 482.92 | 305.88 |
| Profit from discontinuing operations (after tax) | 0.00 | 0.00 |
| Net profit/loss | 482.92 | 305.88 |
| Particulars | 31 March 2022 | 31 March 2021 |
| Cash flows from used in operating activities | ||
| Profit before extraordinary items and tax | 661.03 | 472.69 |
| Adjustments for reconcile profit (loss) | ||
| Adjustments to profit (loss) | ||
| Adjustments for finance costs | 34.25 | 65.89 |
| Adjustments for depreciation and amortisation expense | 205.65 | 222.2 |
| Other adjustments to reconcile profit (loss) | 0 | -0.68 |
| Other adjustments for non-cash items | 3.78 | 8.07 |
| Total adjustments to profit (loss) | 243.68 | 295.48 |
| Adjustments for working capital | ||
| Adjustments for decrease (increase) in inventories | 76.62 | 103.98 |
| Adjustments for decrease (increase) in trade receivables | -818.6 | 67.75 |
| Adjustments for decrease (increase) in other current assets | -17.04 | 15.47 |
| Adjustments for increase (decrease) in trade payables | 259.36 | -126.49 |
| Adjustments for increase (decrease) in other current liabilities | -14.38 | 6.49 |
| Adjustments for provisions | 157.24 | 86.68 |
| Total adjustments for working capital | -356.8 | 153.88 |
| Total adjustments for reconcile profit (loss) | -113.12 | 449.36 |
| Net cash flows from (used in) operations | 547.91 | 922.05 |
| Income taxes paid (refund) | 203.54 | 167.57 |
| Net cash flows from (used in) operating activities before extraordinary items | 344.37 | 754.48 |
| Net cash flows from (used in) operating activities | 344.37 | 754.48 |
| Cash flows from/used in investing activities | ||
| Proceeds from sales of tangible assets | 4.45 | 6.53 |
| Purchase of tangible assets | 120.26 | 139.13 |
| Other inflows (outflows) of cash | -430.84 | 0.4 |
| Net cash flows from (used in) investing activities before extraordinary items | -546.65 | -132.2 |
| Net cash flows from (used in) investing activities | -546.65 | -132.2 |
| Cash flows from/used in financing activities | ||
| Proceeds from borrowings | 185.02 | -461.32 |
| Repayments of borrowings | 64 | -50 |
| Interest paid | 34.24 | 65.89 |
| Net cash flows from (used in) financing activities before extraordinary items | 86.78 | -477.21 |
| Net cash flows from (used in) financing activities | 86.78 | -477.21 |
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -115.5 | 145.07 |
| Net increase (decrease) in cash and cash equivalents | -115.5 | 145.07 |
| Cash and cash equivalents cash flow statement at end of period | 106.56 | 222.06 |
Here is a summary of the Cash Flow Statement for the years 2022 and 2021 broken down by activity wise in rupees:
Cash Flows from Operating Activities:
1. Net Cash Flows from Operating Activities:
- In 2022, the net cash generated from operating activities was ₹344.37 lakhs, which is significantly lower than the previous year 's figure of ₹754.48 lakhs in 2021.
- This decrease indicates a reduction in the cash generated from core business operations.
2. Adjustments for Reconciliation of Profit (Loss):
- Various adjustments are made to reconcile the reported profit (loss) to the cash provided by operating activities.
- These adjustments include finance costs, depreciation, amortization expenses, and other non-cash items, totaling ₹113.12 lakhs in 2022 and ₹449.36 lakhs in 2021.
3. Adjustments for Working Capital:
- Adjustments are made for changes in working capital components like inventories, trade receivables, trade payables, and provisions.
- In 2022, there was a net decrease in working capital adjustments of ₹356.8 lakhs, compared to an increase of ₹153.88 lakhs in 2021.
Cash Flows from Investing Activities:
4. Net Cash Flows from Investing Activities:
- The net cash used in investing activities was -₹546.65 lakhs in 2022 and -₹132.2 lakhs in 2021.
- This includes proceeds from sales of tangible assets, purchase of tangible assets, and other inflows/outflows of cash related to investments.
Cash Flows from Financing Activities:
5. Net Cash Flows from Financing Activities:
- Financing activities include proceeds from borrowings, repayments of borrowings, and interest paid.
- In 2022, there was a net cash inflow of ₹86.78 lakhs from financing activities, while in 2021, there was a net outflow of -₹477.21 lakhs.
Overall Cash Flow:
6. Net Increase (Decrease) in Cash and Cash Equivalents:
- The net increase (decrease) in cash and cash equivalents before the effect of exchange rate changes was -₹115.5 lakhs in 2022 and ₹145.07 lakhs in 2021.
- This indicates the change in the company 's cash position before considering the impact of exchange rate fluctuations.
7. Cash and Cash Equivalents at the End of the Period:
- As of March 31, 2022, the cash and cash equivalents on the balance sheet were ₹106.56 lakhs, whereas in 2021, it was ₹222.06 lakhs.
|
Particulars |
2022 |
|
Dividend (final + interim) (In Rs.) |
2 |
